Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease

Individuals with mild cognitive impairment (MCI) are clinically heterogeneous, with different risks of progression to Alzheimer’s disease. Regular follow-up and examination may be time-consuming and costly, especially for MRI and PET. Therefore, it is necessary to identify a more precise MRI populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Xiao-Yan, Cui, Kai, Liu, Long, Qin, Yao, Cui, Jing, Han, Hong-Juan, Luo, Yan-Hong, Yu, Hong-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413294/
https://www.ncbi.nlm.nih.gov/pubmed/34475445
http://dx.doi.org/10.1038/s41598-021-96914-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413294/
https://www.ncbi.nlm.nih.gov/pubmed/34475445
http://dx.doi.org/10.1038/s41598-021-96914-3

Ejemplares similares